Verition Fund Management
BMY icon

Verition Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Verition Fund Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.2M Buy
90,300
+14,500
+19% +$833K 0.03% 633
2026
Q1 		$4.6M Buy
75,800
+34,300
+83% +$2M 0.03% 620
2025
Q4 		$2.24M Sell
41,500
-6,600
-14% -$318K 0.01% 1501
2025
Q3 		$2.17M Buy
48,100
+8,400
+21% +$392K 0.01% 1907
2025
Q2 		$1.84M Buy
39,700
+7,400
+23% +$363K 0.01% 2019
2025
Q1 		$1.97M Buy
32,300
+23,500
+267% +$1.37M 0.01% 1584
2024
Q4 		$498K Hold
8,800
– – ﹤0.01% 2492
2024
Q3 		$455K Hold
8,800
– – ﹤0.01% 2373
2024
Q2 		$365K Sell
8,800
-6,100
-41% -$273K ﹤0.01% 2235
2024
Q1 		$808K Sell
14,900
-500
-3% -$25.5K 0.01% 1737
2023
Q4 		$790K Sell
15,400
-26,200
-63% -$1.38M 0.01% 1285
2023
Q3 		$2.41M Buy
+41,600
New +$2.55M 0.03% 702
2023
Q1 		– Sell
-14,600
Closed -$1.05M – 2168
2022
Q4 		$1.05M Sell
14,600
-7,200
-33% -$543K 0.02% 896
2022
Q3 		$1.55M Buy
+21,800
New +$1.58M 0.02% 1083
2022
Q2 		– Sell
-30,200
Closed -$2.21M – 2391
2022
Q1 		$2.21M Buy
30,200
+8,000
+36% +$537K 0.03% 898
2021
Q4 		$1.38M Buy
+22,200
New +$1.3M 0.01% 1096
2020
Q2 		– Sell
-255,500
Closed -$14.2M – 1064
2020
Q1 		$14.2M Sell
255,500
-797,900
-76% -$48.8M 0.56% 43
2019
Q4 		$67.1M Buy
1,053,400
+879,600
+506% +$50.4M 1.22% 17
2019
Q3 		$8.74M Buy
173,800
+52,500
+43% +$2.47M 0.24% 69
2019
Q2 		$5.5M Buy
+121,300
New +$5.65M 0.15% 105

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Verition Fund Management's BMY Position: Q2 2026 in Review

Verition Fund Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 6,487 shares worth $374K. The stake represents ﹤0.01% of the portfolio and ranks #1711 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in BMY as recently as Q4 2025.

Verition Fund Management first reported a position in BMY in Q3 2013 and has held it in 38 quarters since. The position peaked at $15.9M in Q3 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Verition Fund Management held 6,487 shares of Bristol-Myers Squibb worth $374K as of Q2 2026.
  • Bristol-Myers Squibb was a new Verition Fund Management position in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #1711 holding.
  • Verition Fund Management first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 38 quarters since.
  • Verition Fund Management's Bristol-Myers Squibb position peaked at $15.9M in Q3 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.